Loading...
•
Sep 30, 2023
Cerus Q3 2023 Earnings Report
Announced financial results for the third quarter ended September 30, 2023
Key Takeaways
Cerus Corporation reported total revenue of $47.3 million for Q3 2023, consisting of $39.8 million in product revenue and $7.5 million in government contract revenue. The company is adjusting its full-year 2023 product revenue guidance to a range of $155 million to $158 million.
Total revenue for Q3 2023 reached $47.3 million, including $39.8 million from product revenue and $7.5 million from government contracts.
Phase 3 ReCePI study enrollment completed in cardiovascular surgery patients, with top-line data expected in Q1 2024.
Cash, cash equivalents, and short-term investments totaled $79.0 million as of September 30, 2023.
Commitment to achieve non-GAAP adjusted EBITDA breakeven reaffirmed for the fourth quarter of 2023.
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company expects full-year 2023 product revenue to be in the range of $155 million to $158 million and remains committed to achieving non-GAAP adjusted EBITDA breakeven during the fourth quarter of 2023.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...